EE155 Cost Analysis of Polatuzumab Vedotin in Combination With Rituximab Cyclophosphamide Doxorubicin and Prednisone in the Treatment of Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma in Portugal
Abstract
Authors
Bernardete Pinheiro Ana Salomé Correia Pedro Carvalho Daniela Alves Herlander Marques José Mário Mariz Marília Gomes Rodrigo Ho Aino Launonen Catarina Pereira Margarida Borges